Skip to search formSkip to main contentSkip to account menu

Fluorouracil/Irinotecan/Leucovorin Calcium regimen (IFL)

Known as: IFL, Saltz Regimen, 5FU/Leucovorin/Irinotecan 
A combination of agents containing fluorouracil, irinotecan and leucovorin calcium.
National Institutes of Health

Related topics

Related topics

4 relations
FluorouracilIrinotecan hydrochlorideLeucovorin Calciumirinotecan

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Inspiratory flow limitation in a normal population of adults in São Paulo, Brazil.
STUDY OBJECTIVES Inspiratory flow limitation (IFL) during sleep occurs when airflow remains constant despite an increase in… 
2008
2008
Health-related quality of life impact of bevacizumab when combined with irinotecan, 5-fluorouracil, and leucovorin or 5-fluorouracil and leucovorin for metastatic colorectal cancer.
PURPOSE To compare the time to deterioration in health-related quality of life (HRQoL) in patients with previously untreated… 
Highly Cited
2006
Highly Cited
2006
Risk factors for gastrointestinal perforations in patients with metastatic colorectal cancer receiving bevacizumab plus chemotherapy.
3535 Background: Bevacizumab (BV) prolongs overall survival and progression-free survival when added to standard chemotherapy in… 
Highly Cited
2006
Highly Cited
2006
A randomized trial of first-line irinotecan/fluoropymidine combinations with or without celecoxib in metastatic colorectal cancer (BICC-C).
3506 Background: This multicenter, randomized study assessed efficacy & safety for 3 irinotecan/fluoropyrimidines combinations in… 
Highly Cited
2004
Highly Cited
2004
Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803).
3500 Background: Irinotecan prolongs survival in second line 5FU-refractory metastatic colorectal cancer (MCRC). First line… 
Highly Cited
2004
Highly Cited
2004
Irinotecan plus fluorouracil/leucovorin (IFL) versus fluorouracil/leucovorin alone (FL) in stage III colon cancer (intergroup trial CALGB C89803)
3500 Background: Irinotecan prolongs survival in second line 5FU-refractory metastatic colorectal cancer (MCRC). First line… 
2004
2004
Bevacizumab (BV) plus 5-FU/leucovorin (FU/LV) for advanced colorectal cancer (CRC) that progressed after standard chemotherapies: An NCI Treatment Referral Center trial (TRC-0301).
3515 Background: The addition of bevacizumab (BV, Avastin) to IFL for untreated metastatic CRC produces survival benefit (Hurwitz… 
Highly Cited
2004
Highly Cited
2004
OPTIMOX study: FOLFOX 7/LV5FU2 compared to FOLFOX 4 in patients with advanced colorectal cancer.
3525 Background: FOLFOX4 has shown superiority over LV5FU2 and IFL in first line therapy. Limiting toxicities are neutropenia… 
Highly Cited
1997
Highly Cited
1997
Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
BACKGROUND The purpose of this study was to investigate whether obliterative bronchiolitis might occur after xenogenic pulmonary… 
Highly Cited
1985
Highly Cited
1985
Can antigliadin antibody detect symptomless coeliac disease in children with short stature?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)